Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities.
The loss of function or dysfunction of beta-cells in the pancreas, attributed to the development of diabetes, involve alterations in genetic and epigenetic signatures. Recent evidences highlight the pathophysiological role of histone deacetylases (HDACs) ..... Read More